Product Information

CAPECITABINE 150 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3615 per EA under NDC 00093747306. Its NADAC has been published 209 times since Nov 19, 2014.

FDA first approved this application on Sep 16, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CAPECITABINE 150 MG TABLET

Capecitabine
$0.3615per EA

Strength

150 mg/1

NDC

00093747306

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

6/17/2026

Active Ingredients

CAPECITABINE

Approval Type

Generic (ANDA)

FDA Application

ANDA091649

FDA Approved

9/16/2013

TE Code

AB

On Market Since

3/7/2014

Pharmacological Classes

Nucleic Acid Synthesis Inhibitors
Nucleoside Metabolic Inhibitor

Price Statistics

The NADAC for CAPECITABINE 150 MG TABLET has been published 209 times since Nov 19, 2014, and over the history we have for it it has declined 95.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3615 per EA
All-time high$8.2671 (Jul 15, 2015)
All-time low$0.2292 (Mar 19, 2025)
52-week high$0.4038
52-week low$0.3615
Median price$0.4361
Average price$3.5312
Largest weekly change-92.6% (May 22, 2024)
Weeks tracked209
Tracking sinceNov 19, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-8.6%

1Y

-10.5%

3Y

-95.0%

5Y

-95.0%

All

-95.6%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CAPECITABINE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3615 per EA (NDC 00093747306), effective Aug 19, 2026.

How has the price of CAPECITABINE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has declined 95.6%. It has been tracked across 209 weekly CMS publications since Nov 19, 2014.

What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?

Since Nov 19, 2014, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2292 (Mar 19, 2025) to a high of $8.2671 (Jul 15, 2015), with a median of $0.4361 per EA.

Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPECITABINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CAPECITABINE 150 MG TABLET?

CAPECITABINE 150 MG TABLET (NDC 00093747306) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.